E-ISSN 2231-3206 | ISSN 2320-4672
 

Review Article 


Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.

Ashok Jaiswal.


Abstract
The prevalence of cardiovascular diseases is rapidly rising. In India, coronary artery disease is one of the leading causes of death. Evidence based guidelines are recommending multiple drug therapy (statins, aspirin, ACE-I and beta-blockers) for the prevention of CAD. Clinical data for the secondary prevention of CAD are endorsing significant mortality benefits with these evidence based therapy. In real life clinical practice, there is inadequacy of prescription for these evidence based poly-pharmacotherapy for the prevention of CAD. Further, chronic poly-pharmacotherapy is associated with poor adherence to the treatment. This poor adherence to the chronic preventive therapy has been found to be one of the major indicators for poor clinical outcome. Various clinical studies have established that FDC are associated with better patients’ compliance which can translate into better clinical outcome.

Key words: Coronary artery disease, Pollypill, Aspirin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ashok Jaiswal
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol. 2011; 1(1): 9-22.


Web Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. https://www.njppp.com/?mno=6590 [Access: October 04, 2024].


AMA (American Medical Association) Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol. 2011; 1(1): 9-22.



Vancouver/ICMJE Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol. (2011), [cited October 04, 2024]; 1(1): 9-22.



Harvard Style

Ashok Jaiswal (2011) Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol, 1 (1), 9-22.



Turabian Style

Ashok Jaiswal. 2011. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. National Journal of Physiology, Pharmacy and Pharmacology, 1 (1), 9-22.



Chicago Style

Ashok Jaiswal. "Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.." National Journal of Physiology, Pharmacy and Pharmacology 1 (2011), 9-22.



MLA (The Modern Language Association) Style

Ashok Jaiswal. "Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.." National Journal of Physiology, Pharmacy and Pharmacology 1.1 (2011), 9-22. Print.



APA (American Psychological Association) Style

Ashok Jaiswal (2011) Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. National Journal of Physiology, Pharmacy and Pharmacology, 1 (1), 9-22.





Most Viewed Articles
Most Accessed Articles

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Assessment of Nutritional Status of Pregnant Women Attending the City Tebessa PMI (Algeria) [English]
    Taleb Salima, Kaibi Mounira, Deghboudj Nadjia
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 97-105
    » Abstract

  • Difference in pulmonary function test among the athletic and sedentary population
    ShobhaRani Vedala, Niranjan Paul, Abhay B Mane
    Natl J Physiol Pharm Pharmacol. 2013; 3(2): 118-123
    » Abstract » doi: 10.5455/njppp.2013.3.109-114

  • Most Downloaded
    Top Downloaded Articles

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • Evaluation of potential drug-drug interaction in indoor patients of pediatric department of tertiary care hospital
    Simran Patel, Mayur Chaudhari, Nrupal Patel
    Natl J Physiol Pharm Pharmacol. 2019; 9(10): 1012-1016
    » Abstract » doi: 10.5455/njppp.2019.9.0725209072019

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Analyzing Pharmaceutical Industry [English]
    Veselin Tima Dickov, Dragan Mitrovic, Boris Milan Kuzman
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 1-8
    » Abstract » doi: 10.5455/njppp.2011.1.1-8

  • Most Cited Articles
    Most Cited Articles